BusinessProteon Therapeutics Announces Third Quarter 2016 Financial ResultsBy Nasdaq OMXNov 7, 2016, 1:01 PM UTC
BusinessProteon Therapeutics Appoints Paul Hastings Chairman of Its Board of DirectorsBy Nasdaq OMXOct 20, 2016, 12:00 PM UTC
BusinessProteon Therapeutics to Present at Two Upcoming Investor ConferencesBy Nasdaq OMXSep 1, 2016, 12:00 PM UTC
BusinessProteon Therapeutics Announces Publication in the Journal of Cardiovascular Pharmacology of Promising Nonclinical Results for Vonapanitase in Peripheral Artery DiseaseBy Nasdaq OMXApr 13, 2016, 12:00 PM UTC
BusinessProteon Therapeutics Announces Fourth Quarter and Full-Year 2015 Financial ResultsBy Nasdaq OMXMar 14, 2016, 12:30 PM UTC
BusinessProteon Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference on March 8thBy Nasdaq OMXMar 2, 2016, 10:00 PM UTC
BusinessRockwell Medical Enters Into Exclusive License Agreement With Wanbang Biopharmaceutical Co., Ltd. to Commercialize Triferic® in ChinaBy Nasdaq OMXFeb 16, 2016, 1:00 PM UTC
BusinessProteon Therapeutics to Present at the 2016 BIO CEO & Investor Conference February 8thBy Nasdaq OMXFeb 2, 2016, 1:00 PM UTC
